Skip to main content
Premium Trial:

Request an Annual Quote

Carolyn Compton, Caren Mason

HealthTell said this week that Carolyn Compton and Caren Mason have joined the company's board of directors.

Compton is chief medical officer of the National Biomarkers Development Alliance at Arizona State Universitywhere she is also a professor of life sciences.

Mason was formerly CEO of Verinata Health, which was acquired by Illumina in 2013. Before that she was CEO of Quidel.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.